Ocean Biomedical, Inc.

Ocean Biomedical, Inc. (ticker: AEHA) is a biopharmaceutical company that completed its business combination with Aesther Healthcare Acquisition Corp, a blank-check company that IPO'd in 2021 targeting the healthcare and life sciences sector. Sponsored by Aesther Healthcare, the SPAC merged with Ocean Biomedical — a Brown University-affiliated company focused on oncology, fibrosis, and infectious disease therapeutics — with the transaction closing in early 2023. The September 2023 8-K filing reflects activity in the company's post-combination period, during which Ocean Biomedical continued to advance its pipeline as a publicly traded entity. For complete filing history, sponsor details, and deal analytics on Ocean Biomedical and hundreds of other SPAC transactions, sign up for full data access at SpacDesk.